These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28348458)

  • 21. Cortical excitability and plasticity in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of transcranial magnetic stimulation studies.
    Chou YH; Sundman M; Ton That V; Green J; Trapani C
    Ageing Res Rev; 2022 Aug; 79():101660. PubMed ID: 35680080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular Cognitive Impairment (VCI).
    Rundek T; Tolea M; Ariko T; Fagerli EA; Camargo CJ
    Neurotherapeutics; 2022 Jan; 19(1):68-88. PubMed ID: 34939171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcranial magnetic stimulation: Emerging biomarkers and novel therapeutics in Alzheimer's disease.
    Koch G; Martorana A; Caltagirone C
    Neurosci Lett; 2020 Feb; 719():134355. PubMed ID: 31260726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular cognitive impairment.
    O'Brien JT
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):724-33. PubMed ID: 16943169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratio of apoB/LDL: a potential clinical index for vascular cognitive impairment.
    Qian C; Tan F
    BMC Neurol; 2016 Nov; 16(1):243. PubMed ID: 27887584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TMS follow-up study in patients with vascular cognitive impairment-no dementia.
    Bella R; Ferri R; Lanza G; Cantone M; Pennisi M; Puglisi V; Vinciguerra L; Spampinato C; Mazza T; Malaguarnera G; Pennisi G
    Neurosci Lett; 2013 Feb; 534():155-9. PubMed ID: 23274709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive review of transcranial magnetic stimulation in secondary dementia.
    Lanza G; Fisicaro F; Dubbioso R; Ranieri F; Chistyakov AV; Cantone M; Pennisi M; Grasso AA; Bella R; Di Lazzaro V
    Front Aging Neurosci; 2022; 14():995000. PubMed ID: 36225892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study.
    Julkunen P; Jauhiainen AM; Westerén-Punnonen S; Pirinen E; Soininen H; Könönen M; Pääkkönen A; Määttä S; Karhu J
    J Neurosci Methods; 2008 Jul; 172(2):270-6. PubMed ID: 18533272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive Impairment and Celiac Disease: Is Transcranial Magnetic Stimulation a
    Lanza G; Bella R; Cantone M; Pennisi G; Ferri R; Pennisi M
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMS-EEG: A window into the neurophysiological effects of transcranial electrical stimulation in non-motor brain regions.
    Hill AT; Rogasch NC; Fitzgerald PB; Hoy KE
    Neurosci Biobehav Rev; 2016 May; 64():175-84. PubMed ID: 26959337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
    Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
    Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.
    Román GC; Sachdev P; Royall DR; Bullock RA; Orgogozo JM; López-Pousa S; Arizaga R; Wallin A
    J Neurol Sci; 2004 Nov; 226(1-2):81-7. PubMed ID: 15537526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive brain stimulation to assess and modulate neuroplasticity in Alzheimer's disease.
    Boggio PS; Valasek CA; Campanhã C; Giglio AC; Baptista NI; Lapenta OM; Fregni F
    Neuropsychol Rehabil; 2011 Oct; 21(5):703-16. PubMed ID: 21942868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of vascular damage in dementia.
    Biessels GJ
    Biochim Biophys Acta; 2016 May; 1862(5):869-77. PubMed ID: 26612719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMS study.
    Nardone R; De Blasi P; Seidl M; Höller Y; Caleri F; Tezzon F; Ladurner G; Golaszewski S; Trinka E
    J Neural Transm (Vienna); 2011 Sep; 118(9):1349-58. PubMed ID: 21516477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular cognitive impairment: current concepts and clinical developments.
    Moorhouse P; Rockwood K
    Lancet Neurol; 2008 Mar; 7(3):246-55. PubMed ID: 18275926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review.
    Torres-Simón L; Doval S; Nebreda A; Llinas SJ; Marsh EB; Maestú F
    Neuroimage Clin; 2022; 35():103040. PubMed ID: 35653914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular cognitive impairment.
    van der Flier WM; Skoog I; Schneider JA; Pantoni L; Mok V; Chen CLH; Scheltens P
    Nat Rev Dis Primers; 2018 Feb; 4():18003. PubMed ID: 29446769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcranial magnetic stimulation in cognitive rehabilitation.
    Miniussi C; Rossini PM
    Neuropsychol Rehabil; 2011 Oct; 21(5):579-601. PubMed ID: 21462081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia.
    Rajji TK
    Expert Opin Ther Targets; 2019 Jan; 23(1):21-28. PubMed ID: 30451545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.